|1.||Ayala, Victòria: 1 article (06/2005)|
|2.||Dalfó, Esther: 1 article (06/2005)|
|3.||Prat, Joan: 1 article (06/2005)|
|4.||Portero-Otín, Manuel: 1 article (06/2005)|
|5.||Bellmunt, Maria Josep: 1 article (06/2005)|
|6.||Pamplona, Reinald: 1 article (06/2005)|
|7.||Ferrer, Isidre: 1 article (06/2005)|
01/01/1999 - "The uptake of non-oxidatively modified LDL (acetylated LDL) was sufficient to generate MDA-lys epitope in foam cells, consistent with the hypothesis that atherosclerosis is associated with oxidative events in addition to LDL oxidation. "
01/01/1999 - "MDA-lysine epitope (MDA-lys) is closely associated with atherogenesis and was recognized as marker for oxidation. "
|2.||Alzheimer Disease (Alzheimer's Disease)
06/03/2005 - "Consequently we analyzed (i) the presence and concentrations of glutamic and aminoadipic semialdehydes, N(epsilon)-(carboxymethyl)-lysine, N(epsilon)-(carboxyethyl)-lysine, and N(epsilon)-(malondialdehyde)-lysine by means of gas chromatography/mass spectrometry, (ii) the biological response through expression of the receptor for advanced glycation end products, (iii) the fatty acid composition in brain samples from Alzheimer disease patients and age-matched controls, and (iv) the targets of N(epsilon)-(malondialdehyde)-lysine formation in brain cortex by proteomic techniques. "
|1.||Advanced Glycosylation End Products